PR

Pragna Ravikumar Patoliya

Active Director Designated Partner DIN 11541854
DIN 11541854 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pragna Ravikumar Patoliya

Data last updated:

Pragna Ravikumar Patoliya is a Designated Partner at Akhilam Madhuram Multispeciality Hospital Llp (since 2026).

DIN 11541854
Primary Designation Designated Partner
First Appointment 12 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Feb 20262026Active

Board colleagues of Pragna Ravikumar Patoliya

Directorship timeline

Open interactive timeline →
Akhilam Madhuram Multispeciality Hospital Llp
Premium access

Shareholding and investment profile for Pragna Ravikumar Patoliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pragna Ravikumar Patoliya

Pragna Ravikumar Patoliya currently holds 1 directorship: Akhilam Madhuram Multispeciality Hospital Llp (Designated Partner, since 12 Feb 2026).

Pragna Ravikumar Patoliya was first appointed on 12 Feb 2026 as Designated Partner at Akhilam Madhuram Multispeciality Hospital Llp.

The current boards of Pragna Ravikumar Patoliya's companies include Nimesh Arvindkumar Khirsariya (Akhilam Madhuram Multispeciality Hospital Llp), Pooja Nimesh Khirsariya (Akhilam Madhuram Multispeciality Hospital Llp), Ravi Kumar Rameshbhai Patoliya (Akhilam Madhuram Multispeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available